Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.

American journal of rhinology & allergy - 1 Jul 2020

Lee Saangyoung E, Farzal Zainab, Daniels M Leigh Anne, Thorp Brian D, Zanation Adam M, Senior Brent A, Ebert Charles S, Kimple Adam J

Abstract excerpt

BACKGROUND: Cystic fibrosis (CF) is a genetic disease that may result in multiple systemic disorders and potentially fatal severe respiratory compromise. However, the advent of CF transmembrane conductance regulator (CFTR) modulators has changed the management of CF for patients with select mutations. Although clinical trials have highlighted increased pulmonary function and decreased exacerbations as a result of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminophenols
Share to Aminopyridines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Benzodioxoles

Share to Drug Approval

Share to Nasal Mucosa

Share to Pyrazoles

Share to Pyrrolidines

Share to Quinolones

Source

Open in PubMed Open full text

Identifiers

PMID: 32168995
DOI: 10.1177/1945892420912368
PMCID: PMC7573678

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.PMID 32168995Read ↗

Cystic fibrosis transmembrane conductance receptor modulator therapy in cystic fibrosis, an update.Semantic proximity Read ↗

An update on new and emerging therapies for cystic fibrosis.Semantic proximity Read ↗

Cystic Fibrosis: A Novel Pharmacologic Approach to Cystic Fibrosis Transmembrane Regulator Modulation Therapy.Semantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSemantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators for cystic fibrosis: a new dawn?Semantic proximity Read ↗

CFTR Modulators: Shedding Light on Precision Medicine for Cystic FibrosisSemantic proximity Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Emerging drugs for cystic fibrosisSemantic proximity Read ↗

Cystic fibrosis transmembrane conductance regulator modulators: precision medicine in cystic fibrosisSemantic proximity Read ↗

Small molecule modulators of cystic fibrosis transmembrane conductance regulator (CFTR): Structure, classification, and mechanisms.Semantic proximity Read ↗

Effects of CFTR-modulator triple therapy on sinunasal symptoms in children and adults with cystic fibrosis.Semantic proximity Read ↗

Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.